Hjem › Inflammatorisk tarmsygdom › Washington
Inflammatorisk tarmsygdom kliniske forsøg i Washington
10 studier for Inflammatorisk tarmsygdom søger deltagere på steder i Washington.
Byer i Washington
Officiel studietekst (engelsk)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- University of Washington School Medicine, Seattle
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 30. sep. 2026 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 004, Seattle
- Site 019, Tacoma
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-021, Bellevue
- Site US-029, Tacoma
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07845487Familial Inflammatory Bowel Disease Early Risk
- Seattle Children's Hospital, Seattle
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 0 til 55 · Alle køn · Opdateret 28. aug. 2026 · NCT07791862A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Seattle Children's Hospital, Seattle
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 24. aug. 2026 · NCT05509777Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Seattle Children's Hospital, Seattle
RekruttererFase 4
Alder 6 til 17 · Alle køn · Opdateret 27. maj 2026 · NCT05781152Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
- Seattle Children's Hospital, Seattle
RekruttererObservationsstudie
Alder 6 til 21 · Alle køn · Opdateret 24. apr. 2026 · NCT06315179A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Bellevue
- Mirador Therapeutics Selected Site, Silverdale
- Mirador Therapeutics Selected Site, Tacoma
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
- Liver institute Northwest, Seattle
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 24. okt. 2025 · NCT06699121Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
- Seattle Children's Hospital, Seattle
Rekrutterer
Alder 8 til 21 · Alle køn · Opdateret 12. jun. 2025 · NCT06216899Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.